Pesquisar | Mạng Xã Hội Linux

Shreya Patil adicionou um novo artigo Outro
2025-09-16 04:55:35 -

Cancer Immunotherapy Market Size, Key Drivers, Demand and Opportunity Analysis
Cancer Immunotherapy Market Segmentation, By Product Type (Checkpoint Inhibitors, Monoclonal Antibodies, Vaccines, Cell Therapies, Immunomodulators and Oncolytic Virus), Application (Lung Cancer, Breast Cancer, Melanoma, Multiple Myeloma, Prostate Cancer, Ovarian Cancer, Cervical Cancer, Stomach Cancer, Colorectal Cancer, Head & Neck Cancer, and Others), End User (Hospitals, Oncology...

0 Comentários 0 Compartilhamentos 287 Visualizações

Faça Login para curtir, compartilhar e comentar!
Shreya Patil adicionou um novo artigo Outro
2025-09-22 05:36:45 -

Cancer Immunotherapy Market Size, Share, Growth, Trends, Demand and Opportunity Analysis
Cancer Immunotherapy Market Segmentation, By Product Type (Checkpoint Inhibitors, Monoclonal Antibodies, Vaccines, Cell Therapies, Immunomodulators and Oncolytic Virus), Application (Lung Cancer, Breast Cancer, Melanoma, Multiple Myeloma, Prostate Cancer, Ovarian Cancer, Cervical Cancer, Stomach Cancer, Colorectal Cancer, Head & Neck Cancer, and Others), End User (Hospitals, Oncology...

0 Comentários 0 Compartilhamentos 239 Visualizações

Faça Login para curtir, compartilhar e comentar!
Shreya Patil adicionou um novo artigo Outro
2025-10-08 10:15:30 -

Cancer Immunotherapy Market Size, Share, Trends, Demand, Growth and Competitive Analysis
The Cancer Immunotherapy Market Report provides an insightful evaluation of market conditions, including size, trends, and emerging opportunities. It examines competitive forces, market drivers, and technology adoption across industries. The study also offers profiles of key players and analyzes their market strategies. This report segments the market by type, application, and region,...

0 Comentários 0 Compartilhamentos 280 Visualizações

Faça Login para curtir, compartilhar e comentar!
Vikas Kokate adicionou um novo artigo Party
2025-09-15 10:12:32 -

Immune Checkpoint Inhibitors Market Overview, Growth Analysis, Trends and Forecast By 2029
"Latest Insights on Executive Summary Immune Checkpoint Inhibitors Market Share and Size Immune checkpoint inhibitors market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 18.2% in the above mentioned forecast period. Immune Checkpoint Inhibitors Market report presents the best market...

0 Comentários 0 Compartilhamentos 336 Visualizações

Faça Login para curtir, compartilhar e comentar!
Vikas Kokate adicionou um novo artigo Outro
2025-07-10 12:05:59 -

Immuno-Oncology (IO) Market Overview, Growth Analysis, Trends and Forecast By 2030
"Executive Summary Immuno-Oncology (IO) Market : Data Bridge Market Research analyses that the immuno-oncology (IO) market, which is USD 28.10 billion in 2022, is expected to reach USD 156.05 billion by 2030, at a CAGR of 23.9% during the forecast period 2023 to 2030. The Immuno-Oncology (IO) Market report is bifurcated into several attributes which include manufacturers, region,...

0 Comentários 0 Compartilhamentos 365 Visualizações

Faça Login para curtir, compartilhar e comentar!
Vikas Kokate adicionou um novo artigo Outro
2025-09-12 07:41:42 -

Recombinant Cytokines Market Overview, Growth Analysis, Trends and Forecast By 2030
"Executive Summary Recombinant Cytokines Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global recombinant cytokines market which was USD 2.78 million in 2022, is expected to reach USD 4.20 million by 2030, and is likely to undergo a CAGR of 5.4% during the forecast period. For an excellent outcome of Recombinant Cytokines Market report,...

0 Comentários 0 Compartilhamentos 296 Visualizações

Faça Login para curtir, compartilhar e comentar!
Gemini Smith adicionou um novo artigo Health
2025-10-24 08:05:59 -

The Rise of PD-(L)1 Bispecific Antibodies in Cancer Immunotherapy
In recent years, immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, reshaping traditional therapeutic strategies. Among them, PD-1/PD-L1 pathway inhibitors have achieved remarkable clinical success across multiple cancer types. As PD-(L)1 inhibitor therapies mature, pharmaceutical leaders are now focusing on PD-(L)1 bispecific antibodies (BsAbs)—a next-generation...

0 Comentários 0 Compartilhamentos 307 Visualizações

Faça Login para curtir, compartilhar e comentar!